# Meihua Yiliao

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/meihua-yiliao

- Industry: Medical Devices & Equipment
- Headquarters: Zhuhai, China
- Total disclosed funding: $14M
- Latest round: Series B (Dec 19, 2022)
- Investors on record: 4

## About

Based in Zhuhai, China, and established in 2010, Meihua Yiliao is a medical equipment company that engages in the R&D, manufacturing, and sales of clinical IVD instruments and supporting reagents. It has domestic and abroad R&D team members and more than 40 patents. And its products are sold in 40 countries and regions.

Meihua Yiliao's products include MALDI-TOF microbial mass spectrometry rapid identification and analysis systems, and microbial identification and drug susceptibility analysis systems.  It also provides over 30 in vitro diagnostic instruments and supporting reagents, such as automatic blood culture analysis systems, microbiological laboratory management analysis systems, microbiological culture medium series products, and microbiological laboratory automation auxiliary equipment. Besides, it also provides laboratory informatization management systems.

## Funding rounds

- Series B, Dec 19, 2022, $14M — Eight Roads Ventures, Sunland Capital, Zhuhai Science & Technology Venture, Hangzhou Qianhe Private Equity Fund Management

## Investors

- Eight Roads Ventures (https://capitalatlas.ai/funds/eight-roads-ventures) — Series B
- Sunland Capital — Series B
- Zhuhai Science & Technology Venture — Series B
- Hangzhou Qianhe Private Equity Fund Management (https://capitalatlas.ai/funds/hangzhou-qianhe-private-equity-fund-management) — Series B